Effects of Acute Intracerebroventricular Microinfusions of Bupropion on Background Spike Activity of Locus Coeruleus Neurons in Rats

Considering that noradrenergic (NAE) neurons of the locus coeruleus (LC) play significant roles in the formation of biological rhythms, pain, addictions, and mood disorders, we tested the effects of acute intracerebroventricular microinfusions of bupropion, an inhibitor of NA reuptake used in cli...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2014
Автори: Pakdel, F.G., Amirabadi, S., Naderi, S., Osalou, M.A., Cankurt, U., Jahanbani, M., Shahabi, P.
Формат: Стаття
Мова:English
Опубліковано: Інститут фізіології ім. О.О. Богомольця НАН України 2014
Назва видання:Нейрофизиология
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/148304
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Effects of Acute Intracerebroventricular Microinfusions of Bupropion on Background Spike Activity of Locus Coeruleus Neurons in Rats / F.G. Pakdel, S. Amirabadi, S. Naderi, M.A. Osalou, U. Cankurt, M. Jahanbani, P. Shahabi // Нейрофизиология. — 2014. — Т. 46, № 4. — С. 352-358. — Бібліогр.: 37 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
Опис
Резюме:Considering that noradrenergic (NAE) neurons of the locus coeruleus (LC) play significant roles in the formation of biological rhythms, pain, addictions, and mood disorders, we tested the effects of acute intracerebroventricular microinfusions of bupropion, an inhibitor of NA reuptake used in clinics as an antidepressant, on background spike activity on LC neurons in chloral-hydrate anesthetized rats. Ten microliters of the solutions containing 0.001, 0.01, 0.1, 1.0, or 10.0 µmol bupropion were infused during 3 min; spike activity of single LC neurons identified according to the known characteristics was recorded extracellularly by glass microelectrodes. Microinfusions of 0.01 to 10.0 µmol bupropion suppressed background spiking of the above neurons in a dose-dependent manner. The normalized mean intensities and durations of inhibition were 17.3, 19.4, 26.3, and 41.1% and 1.4, 7.1, 12.4, and 18.3 min, respectively. The smallest dose (0.001 µmol) was ineffective. It is assumed that bupropion increases the NA level in proximity to NAE LC neurons. The actions of bupropion on other cerebral neuromodulatory systems need further examination. Inhibition of LC neuronal activity by bupropion can help to explain some acute, chronic, and side effects of this agent used in clinics for correction of mood disorders.